Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Naveen Garg Image

      Naveen Garg, M.D.

      Department of Abdominal Imaging, Division of Diagnostic Imaging

      About Dr. Garg

      Dr. Naveen Garg is Professor of Radiology in the Abdominal Imaging section at The University of Texas MD Anderson Cancer Center. He obtained his M.D. from The University of Texas Southwestern Medical School in Dallas, Texas in 2004. He completed his residency from St. Vincent Hospital, in Worchester, Massachusetts in 2005, and his fellowship in body MRI from The University of Texas Houston before joining MD Anderson Cancer Center in 2010.


      Dr. Garg is interested in improving the practice of radiology using artificial intelligence. His research interests include development of radiologist user interface tools, imaging segmentation, search and analytics of the electronic medical record, and deep learning with convolutional nets and transformers.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Associate Member, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Member, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX

      Education & Training

      Degree-Granting Education

      2004UT Southwestern Medical School, Dallas, Texas, US, MD
      2000University of Georgia, Athens, Georgia, US, Biology, BS

      Postgraduate Training

      2009-2010Clinical Fellowship, Body MRI, University of Texas at Houston, Houston, Texas
      2005-2009Clinical Residency, Diagnostic Radiology, St. Vincent Hospital, Worcester, Massachusetts
      2004-2005Clinical Internship, Internal Medicine, University of Texas at Houston, Houston, Texas

      Licenses & Certifications

      2017American Board of Preventive Medicine
      2009American Board of Radiology
      2008Medical Board of California
      2008Composite State Board of Medical Examiners
      2008New York Medical License
      2008Texas Medical Board
      2006Board of Registration in Medicine

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2024

      Associate Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2019

      Faculty, Computational and Integrative Biomedical Research Center, Houston, TX, 2011 - 2015

      Assistant Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2016

      Other Professional Positions

      advisor, Enlitic Inc, San Francisco, CA, 2020 - 2021

      Epic Physician Builder, MD Anderson, Houston, TX, 2016 - 2019

      Consultant, Blackford Analysis Ltd, Pearland, TX, 2014 - 2015

      Consultant, Sage Health Management Solutions, Minneapolis, MN, 2012 - 2015

      Garglab Data Clinic & Analytics, MD Anderson, Houston, TX, 2012 - Present

      Associate Director of Informatics, St. Vincent Hospital, Worcester, MA, 2008 - 2009

      Consultant, AGFA Health Care Inc, Ontario, Canada, 2008 - 2008

      Extramural Institutional Committee Activities

      member, IS governance RAI, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, UT MDACC Diagnostic Imaging EPIC SuperUser, The University of Texas MD Anderson Cancer Center, 2015 - 2019

      Director of Informatics, UT MDACC Diagnostic Radiology - Abdominal Imaging Section, The University of Texas MD Anderson Cancer Center, 2014 - 2015

      Member, UT MDACC ICD-10 Provider Ambassador, The University of Texas MD Anderson Cancer Center, 2014 - 2016

      Member, UT MDACC Abdominal Imaging Section Operations Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015

      Member, UT MDACC Diagnostic Imaging Informatics Functional Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2017

      Member, UT MDACC PET/CT Quality Improvement Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Member, UT MDACC Abdominal Imaging Quality Improvement Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Member, UT MDACC EHR Champion, The University of Texas MD Anderson Cancer Center, 2013 - 2015

      Member, UT MDACC Diagnostic Imaging Powerscribe Implementation Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014

      Member, UT MDACC Diagnostic Imaging Clinical IT Infrastructure Needs Task Force, The University of Texas MD Anderson Cancer Center, 2012 - 2012

      Member, UT MDACC Diagnostic Imaging Informatics Steering Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2014

      Member, UT MDACC EMR Clinical Steering Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2014

      Honors & Awards

      2015Five Year Service Award, The University of Texas MD Anderson Cancer Center
      2013Award Certificate, The University of Texas MD Anderson Cancer Center
      2000 - 2004Out of State Tuition Waiver Scholarship, Southwestern Medical Foundation
      1997 - 2000HOPE Scholarship, State of Georgia

      Professional Memberships

      American College of Radiology (ACR)

      2019 - Present

      The Society of Physician Entrepreneurs - Houston Chapter

      2013 - Present

      American Medical Informatics Association (AMIA)

      2012 - Present

      Radiological Society of North America (RSNA)

      2011 - Present

      Society for Imaging Informatics in Medicine (SiiM)

      2011 - 2020

      Selected Presentations & Talks

      Local Presentations

      1. 2016. Cheson and WHO Criteria. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      2. 2012. Radiology Informatics. Conference. Baylor Medical College. Houston, TX, US.
      3. 2011. Shell/MD Anderson research collaboration. Conference. Shell's Bellaire Technology Center. Houston, TX, US.

      National Presentations

      1. 2019. Artificial Intelligence applications in radiology. Invited. AMDIS, CA, US.
      2. 2019. Medicare Referral Leakage Among Radiology Groups. Conference. ARRS Annual Meeting. Honolulu, HI, US.
      3. 2017. Elastfibroma Dorsi (ED): Cross Sectional imaging findings and Follow up. Conference. Association of University Radiologists 65th Annual Meeting. Hollywood, FL, US.
      4. 2016. Cross sectional imaging of pancreatic masses; pearls, mimics and pitfalls. Conference. 102nd Scientifict Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      5. 2016. Calcified liver masses; pattern recognition approach on computed tomography with pathologic correlation. Conference. 102nd Scientifict Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      6. 2016. Beyond colorectal carcinoma: imaging spectrum of Lynch Syndrome. Conference. 102nd Scientifict Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      7. 2016. Incidental Suspicious Regional Lymph Nodes on Breast Sonography: Is Sampling Necessary?. Conference. 116th Annual Meeting of the American Roentgen Ray Society. Los Angeles, CA, US.
      8. 2015. Added Value of FDG-PET/CT in Detecting Non-peritoneal Metastases in Patients with Gastric Carcinoma. Conference. 101st Scientifict Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      9. 2015. Cross Sectional Imaging of the Spleen; Pearls and Pitfalls. Conference. 101st Scientifict Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      10. 2014. Tubulocystic Renal Cell Carcinoma: A New Recognized Epithelial Tumor. Conference. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America - RSNA Refresher Course program. Chicago, IL, US.
      11. 2014. Phase I Study of Romidepsin in Combination with ICE (Ifosfamide, Carboplatin and Etoposide) in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma. Conference. 56th American Society of Hematology (ASH) Annual Meeting and Exposition. San Francisco, CA, US.
      12. 2014. Aggressive Angiomyxomas: A Comprehensive Imaging Review With Clinical and Histopathological Correlation. Conference. 114th Annual Meeting of the American Roentgen Ray Society. San Diego, CA, US.
      13. 2014. MRI as a Problem Solver: Applications of New Innovations. Conference. SAR 2014 Annual Scientific Meeting and Educational Course. Boca Raton, FL, US.
      14. 2013. Mesenchymal Lesions of the Prostate and Urinary Bladder: Cross Sectional Imaging Spectrum with Pathological Comparison. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      15. 2013. Magnetic Resonance Imaging with Gd-EOB-DTPA: Extrahepatic Pathology. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      16. 2013. Cross-sectional Imaging Spectrum of Hepatic Angiomyolipomas. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      17. 2013. Abdominal Oncologic Applications of Dual Energy CT (DECT): Where do we stand?. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      18. 2013. Improving Radiology Workflow with a Scriptable Automated Protocoller. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      19. 2013. Smarter Communications: Integrating VoIP Solutions for Streamlining Radiology Workflow. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      20. 2013. Complications of Stem Cell Transplantation - Sonographic Findings. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      21. 2013. Cystic Nephroma and Mixed Epithelial and Stromal Tumor of the Kidney: A Single Clinical Entity?. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      22. 2013. Compression of Radiology Reports Using a Semi-static Dictionary and Directed Pseudoforest. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      23. 2012. MDCT urogram spectrum of congenital anomalies of the kidney and urinary tract (CAKUT) in adults. Conference. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      24. 2012. Radiology WYSIWYG teaching files service as a backend and the use of native iOS app. Conference. 98th Scientific Assembly & Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      25. 2012. Partial nephrectomy: the radiologist's role in preoperative imaging, intraoperative surgical guidance and post-treatment complications. Conference. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      26. 2011. A vision for radiology structured reporting. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      27. 2011. An image processing cluster for radiology decision support. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      28. 2011. A vendor-neutral user interface for rapid access to PACS funtionality using hot keys. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      29. 2011. Intelligent hanging protocols using control flow and regular expressions. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      30. 2011. Stereoscopic characterization of breast masses on tomosynthesis projection images. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      31. 2011. Use of multimedia structured reporting to optimize the monitoring of tumor response to anticancer therapy. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      32. 2011. Use of eye-tracking technology and natural language processing for data input into a multimedia structured report. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      33. 2011. Using the iPad to review DICOM images. Conference. The Society for Imaging Informatics in Medicine Annual Meeting 2011. Washington, DC, US.
      34. 2011. Imaging of extrahepatic bile duct cancer : implications of the revised AJCC staging classification. Conference. American Roentgen Ray Society 111th Annual Meeting. Chicago, IL, US.
      35. 2011. Automated midline shift detection on head ct. Conference. American Roentgen Ray Society 111th Annual Meeting. Chicago, IL, US.
      36. 2011. Semiautomated measurements of renal cysts. Conference. American Roentgen Ray Society 111th Annual Meeting. Chicago, IL, US.
      37. 2010. Dynamically switched custom language models for radiology speech recognition. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      38. 2010. Multimedia structured reporting system for tumor monitoring. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      39. 2010. Principles and radiological applications of eye-tracking technology. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      40. 2009. Summary impressions: selecting how many and which prior radiology examinations to review. Conference. 57th Annual Meeting of the Association of University Radiologists. Arlington, VA, US.
      41. 2009. A Radiology Information System (RIS) search-based approach to rare case interpretation. Conference. Annual Meeting of the American Roentgen Ray Society. Boston, MA, US.
      42. 2008. Faster radiology reporting through the utilization of standardized macros. Conference. 56th Annual Meeting of the Association of University Radiologists. Seattle, WA, US.

      International Presentations

      1. 2016. The natural history of heparin-induced thrombocytopenia (HIT) in cancer population: retrospective case series analysis. Conference. American Society of Clinical Oncology Annual Meeting 2016. Chicago, US.
      2. 2015. Utility of PET CT in prediction of response to neo-adjuvant therapy in patients with gastric carcinoma. Conference. European Congress of Radiology Annual Meeting 2015. Vienna, AT.
      3. 2012. Vision for worldwide structured reporting. Conference. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, US.
      4. 2010. Triple inversion recovery imaging of myocardial infarction. Conference. Joint Meeting of the International Society of Magnetic Resonance in Medicine and the European Society of Magnetic Resonance in Medicine and Biology. Stockholm, SE.
      5. 2008. Computer-assisted automatic report generation of DEXA scans. Conference. Indian Radiology and Imaging Association Annual Meeting. Bangalore, IN.

      Formal Peers

      1. 2019. Artificial Intelligence applications in radiology. Visiting. Bangkok, TH.
      2. 2017. EMR Search and Analytics at MD Anderson. Visiting. Houston, TX, US.
      3. 2017. EMR Search and Analytics at MD Anderson. Visiting. Houston, TX, US.
      4. 2012. Visualization Interfaces & Applications Group. Visiting. Austin, TX, US.
      5. 2012. Imaging physics applications and challenges in Diagnostic Radiology. Visiting. Houston, TX, US.
      6. 2012. Medical Student Lecture Series. Visiting. Houston, TX, US.
      7. 2012. Informatics in Oncological Imaging. Visiting. Houston, TX, US.
      8. 2011. Radiology Informatics. Visiting. Houston, TX, US.
      9. 2011. Image processing and Natural Language processing tools for radiology decision support. Visiting. Houston, TX, US.
      10. 2011. Imaging physics applications and challenges in Diagnostic Radiology. Visiting. Houston, TX, US.
      11. 2011. What every radiologist should know about informatics. Visiting. Houston, TX, US.
      12. 2009. Radiology Overview. Visiting. Houston, TX, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Swaminathan M, Ferrajoli A, Thompson PA, Burger J, Borthakur G, Takahashi K, Estrov Z, Bharathi V, Bataller A, Kadia TM, Pemmaraju N, Daver N, Jabbour E, Bose P, Kanagal-Shamanna R, Patel KP, Wang SA, Garg N, Hwang H, Wang X, Qiao W, Xu X, Cruz N, Ayala A, Pierce S, Plunkett W, Sampath D, Kantarjian HM, Keating MJ, Gandhi V, Wierda WG, Jain N. Ibrutinib with venetoclax in patients with relapsed/refractory chronic lymphocytic leukemia: A phase II study. Blood Cancer Discov, 2026. e-Pub 2026. PMID: 41678768.
      2. Huang O, Shi Z, Garg N, Jensen C, Palmeri ML. Automated spontaneous echo contrast detection using a multisequence attention convolutional neural network. Ultrasound Med Biol 50(6):788-796, 2024. e-Pub 2024. PMID: 38461036.
      3. Thompson, PA, Keating, M, Ferrajoli, A, Jain, N, Peterson, CB, Garg, N, Wang, SA, Jorgensen, JL, Kadia, TM, Bose, P, Pemmaraju, N, Short, NJ, Wierda, WG. Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD. Leukemia 37(7):1444-1453, 2023. e-Pub 2023. PMID: 37138019.
      4. Ngo-Huang AT, Parker NH, Xiao L, Schadler KL, Petzel MQB, Prakash LR, Kim MP, Tzeng CD, Lee JE, Ikoma N, Wolff RA, Javle MM, Koay EJ, Pant SD, Folloder JP, Wang X, Cotto AM, Ju YR, Garg N, Wang H, Bruera ED, Basen-Engquist KM, Katz MHG. Effects of a pragmatic home-based exercise program concurrent with neoadjuvant therapy on physical function of patients with pancreatic cancer: the pancfit randomized clinical trial. Ann Surg 278(1):22-30, 2023. e-Pub 2023. PMID: 37026453.
      5. Jain N, Senapati J, Thakral B, Ferrajoli A, Thompson P, Burger J, Basu S, Kadia T, Daver N, Borthakur G, Konopleva M, Pemmaraju N, Parry E, Wu CJ, Khoury J, Bueso-Ramos C, Garg N, Wang X, Lopez W, Ayala A, O'Brien S, Kantarjian H, Keating M, Allison J, Sharma P, Wierda W. A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell richter transformation of CLL. Blood Adv 7(10):1958-1966, 2023. e-Pub 2023. PMID: 36287248.
      6. Thompson PA, Jiang X, Banerjee P, Basar R, Garg N, Chen K, Kaplan M, Nandivada V, Cortes AKN, Ferrajoli A, Keating MJ, Peterson CB, Andreeff M, Rezvani K, Wierda WG. A phase two study of high dose blinatumomab in Richter's syndrome. Leukemia 36(9):2228-2232, 2022. e-Pub 2022. PMID: 35941212.
      7. Park KE, Ramachandran V, Tran J, Joshi TP, Garg N, Duvic M. Association of flame-retardant clothing with mycosis fungoides: a retrospective analysis. Dermatol Pract Concept 12(2):e2022091, 2022. e-Pub 2022. PMID: 35646447.
      8. Aggarwal P, Hutcheson KA, Goepfert RP, Garden AS, Garg N, Mott FE, Fuller CD, Lai SY, Gunn GB, Chambers MS, Hanna EY, Sturgis EM, Shete S. Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors. Head Neck 44(4):952-963, 2022. e-Pub 2022. PMID: 35084077.
      9. Morris V, Kee B, Overman M, Dasari A, Raghav K, Johnson B, Parseghian C, Wolff RA, Garg N, Eng C, Kopetz S. Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer. J Gastrointest Oncol 13(2):647-656, 2022. e-Pub 2022. PMID: 35557581.
      10. Abelhad, NI, Qiao, W, Garg, N, Rojas Hernandez, CM. Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer. Thrombosis Journal 19(1), 2021. e-Pub 2021. PMID: 34074321.
      11. Jain N, Thompson P, Burger J, Ferrajoli A, Takahashi K, Estrov Z, Borthakur G, Bose P, Kadia T, Pemmaraju N, Sasaki K, Konopleva M, Jabbour E, Garg N, Wang X, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang S, Lopez W, Ayala A, Plunkett W, Gandhi V, Kantarjian H, O'Brien S, Keating M, Wierda WG. Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia 35(12):3421-3429, 2021. e-Pub 2021. PMID: 34007049.
      12. Mobiny, A, Yuan, P, Cicalese, PA, Moulik, SK, Garg, N, Wu, CC, Wong, KK, Wong, ST, He, T, Nguyen, HV. Memory-augmented capsule network for adaptable lung nodule classification. IEEE Transactions on Medical Imaging 40(10):2869-2879, 2021. e-Pub 2021. PMID: 33434126.
      13. Jain N, Keating M, Thompson P, Ferrajoli A, Burger JA, Borthakur G, Takahashi K, Estrov Z, Sasaki K, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang SA, Garg N, Wang X, Wei C, Cruz N, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda WG. Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial. JAMA Oncol 7(8):1213-1219, 2021. e-Pub 2021. PMID: 34110383.
      14. Aggarwal P, Goepfert RP, Garden AS, Garg N, Zaveri JS, Du XL, Swartz MD, Lai SY, Fuller CD, Ferrarotto R, Sturgis EM, Piller LB, Hutcheson KA. Risk and clinical risk factors associated with late lower cranial neuropathy in long-term oropharyngeal squamous cell carcinoma survivors. JAMA Otolaryngol Head Neck Surg 147(5):469-478, 2021. e-Pub 2021. PMID: 33538759.
      15. Mobiny A, Yuan P, Moulik SK, Garg N, Wu CC, Van Nguyen H. DropConnect is effective in modeling uncertainty of bayesian deep networks. Sci Rep 11(1):5458, 2021. e-Pub 2021. PMID: 33750847.
      16. Parker, NH, Gorzelitz, J, Ngo-Huang, AT, Caan, BJ, Prakash, L, Garg, N, Petzel, MQ, Schadler, KL, Basen-Engquist, KM, Katz, MH. The role of home-based exercise in maintaining skeletal muscle during preoperative pancreatic cancer treatment. Integrative cancer therapies 20, 2021. e-Pub 2021. PMID: 33870744.
      17. Ngo-Huang A, Herbert A, Fontillas RC, Parker NH, Asumbrado R, Garg N, Dibaj S, Liu DD, Ng AH, Guo Y, Shin KY, Katz MHG, Bruera E. Frequency of sarcopenia, sarcopenic obesity, and changes in physical function in surgical oncology patients referred for prehabilitation. Integr Cancer Ther 20:15347354211000118, 2021. e-Pub 2021. PMID: 33829906.
      18. Bedrose S, Miller KC, Altameemi L, Ali MS, Nassar S, Garg N, Daher M, Eaton KD, Yorio JT, Daniel DB, Campbell M, Bible KC, Ryder M, Chintakuntlawar AV, Amir Habra M. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 32737143.
      19. Elhammali A, Amini B, Ludmir EB, Gunther JR, Milgrom SA, Pinnix CC, Andraos T, Yoder A, Weber D, Orlowski R, Manasanch E, Patel K, Strati P, Nair R, Lee HC, Thomas S, Iyer S, Kaufmann G, Garg N, Dabaja BS. New Paradigm for Radiation in Multiple Myeloma: lower yet effective dose to avoid radiation toxicity. Haematologica 105(7):e355-e357, 2020. e-Pub 2020. PMID: 31919088.
      20. Welborn M, Kubicki SL, Garg N, Patel AB. Twelve cases of acneiform eruptions while on anti-CTLA4 therapy. Support Care Cancer 28(6):2499-2502, 2020. e-Pub 2020. PMID: 32147760.
      21. Elshikh M, Schellingerhout D, Rayan J, Taher A, Elsayes AK, Mujtaba B, Garg N. Disease Characteristics, Radiologic Patterns, Comorbid Diseases, and Ethnic Differences in 32 Patients With Rosai-Dorfman Disease. J Comput Assist Tomogr 44(3):450-461, 2020. e-Pub 2020. PMID: 31972751.
      22. Andrews ED, Garg N, Patel AB. A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor and mitogen-activated protein kinase kinase inhibitor induced acneiform eruptions. J Am Acad Dermatol 82(4):998-1000, 2020. e-Pub 2020. PMID: 31604105.
      23. Elshikh M, Schellingerhout D, Rayan J, Taher A, Elsayes A, Mujtaba B, Garg N. Disease characteristics, radiologic patterns, comorbid diseases, and ethnic differences in 32 patients with rosai-dorfman disease. J Comput Assist Tomography. e-Pub 2020.
      24. Jain N, Keating MJ, Thompson PA, Ferrajoli A, Burger JA, Borthakur GM, Takahashi K, Estrov ZE, Fowler NH, Kadia TM, Konopleva MY, Alvarado Y, Yilmaz M, DiNardo CD, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen JL, Wang SA, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian HM, Gandhi V. Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL). Blood 134(1):34, 2019. e-Pub 2019.
      25. Chong I, Ostrom Q, Dandachi D, Garg N, Kotrotsou A, Colen R, Morón F. Whole tumor histogram analysis using DW MRI in primary central nervous system lymphoma correlates with tumor biomarkers and outcome. Cancers, 2019. e-Pub 2019.
      26. Chong I, Ostrom Q, Khan B, Dandachi D, Garg N, Kotrotsou A, Colen R, Morón F. Whole tumor histogram analysis using DW magnetic resonance imaging (MRI) in primary central nervous system lymphoma correlates with tumor biomarkers and outcome. Cancers (Basel) 11(10), 2019. e-Pub 2019. PMID: 31597366.
      27. Debnam JM, Vu T, Sun J, Wei W, Krishnamurthy S, Zafereo ME, Weitzman SP, Garg N, Ahmed S. Vascular flow on doppler sonography may not be a valid characteristic to distinguish colloid nodules from papillary thyroid carcinoma even when accounting for nodular size. Gland Surg 8(5):461-468, 2019. e-Pub 2019. PMID: 31741876.
      28. Coletta AM, Klopp AH, Fogelman D, Parikh AM, Li Y, Garg N, Basen-Engquist K. Dual-energy X-Ray absorptiometry compared to computed tomography for visceral adiposity assessment among gastrointestinal and pancreatic cancer survivors. Sci Rep 9(1):11500, 2019. e-Pub 2019. PMID: 31395928.
      29. Elhammali A, Milgrom SA, Amini B, Gunther JR, Yoder A, Ludmir EB, Moon B, Weber DM, Thomas SK, Garg N, Manasanch EE, Patel KK, Orlowski RZ, Lee HC, Bird JE, Satcher R, Lin P, Pinnix CC, Dabaja BS. Postoperative radiotherapy for multiple myeloma of long bones: Should the entire rod be treated?. Clin Lymphoma Myeloma Leuk 19(8):e465-e469, 2019. e-Pub 2019. PMID: 31133526.
      30. Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Ju Lee H, Fowler N, Nastoupil L, Neelapu SS, Pinnix CC. Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function. Leukemia & lymphoma:1-5. e-Pub 2019. PMID: 31373240.
      31. Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of curative-intent treatment for patients with breast cancer presenting with sternal or mediastinal involvement. Int J Radiat Oncol Biol Phys 104(3):574-581, 2019. e-Pub 2019. PMID: 30851348.
      32. Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda, W. Ibrutinib and venetoclax for first-line treatment of CLL. N Engl J Med 380(22), 2019. e-Pub 2019.
      33. Parseghian CM, Loree JM, Morris VK, Liu X, Clifton KK, Napolitano S, Henry JT, Pereira AA, Vilar E, Johnson B, Kee B, Raghav K, Dasari A, Wu J, Garg N, Raymond VM, Banks KC, Talasaz AA, Lanman RB, Strickler JH, Hong DS, Corcoran RB, Overman MJ, Kopetz S. Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. Ann Oncol 30(2):243-249, 2019. e-Pub 2019. PMID: 30462160.
      34. Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, Ahmed S, Medeiros LJ, Khoury JD, Garg N, Amini B, Dabaja BS, Pinnix CC. Hitting a moving target: Successful management of diffuse large B-cell lymphoma involving the mesentery with volumetric image-guided intensity modulated radiation therapy. Clin Lymphoma Myeloma Leuk 19(1):e51-e61, 2019. e-Pub 2019. PMID: 30360985.
      35. Welborn M, Kubicki SL, Garg N, Patel AB. Retrospective chart review of cutaneous adverse events associated with Tremelimumab in 17 patients. American journal of clinical dermatology 19(6):899-905, 2018. e-Pub 2018. PMID: 30073495.
      36. Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB. A visually apparent and quantifiable catscan (CT) imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research 24(23):5883-5894, 2018. e-Pub 2018. PMID: 30082477.
      37. Strati P, Chihara D, Oki Y, Fayad LE, Fowler N, Nastoupil L, Romaguera JE, Samaniego F, Garg N, Feng L, Wesson ET, Ruben CE, Stafford MD, Nieto Y, Khouri IF, Hosing C, Horowitz SB, Kamble RT, Fanale MA. A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. Haematologica 103(9):e416-e418, 2018. e-Pub 2018. PMID: 29622656.
      38. Kubicki SL, Welborn ME, Garg N, Aung PP, Patel AB. Granulomatous dermatitis associated with ipilimumab therapy (ipilimumab associated granulomatous dermatitis). Journal of cutaneous pathology 45(8):636-638, 2018. e-Pub 2018. PMID: 29704281.
      39. Patnana M, Menias CO, Pickhardt PJ, Elshikh M, Javadi S, Gaballah A, Shaaban AM, Korivi BR, Garg N, Elsayes KM. Liver calcifications and calcified liver masses: Pattern recognition approach on catscan (CT. AJR American journal of roentgenology 211(1):76-86, 2018. e-Pub 2018. PMID: 29667888.
      40. Khan M, Cox TM, Nassif M, Alzubaidi MA, Garg N, Qiao W, Aung FM, Oo TH, Rojas-Hernandez CM. Comparative outcomes of thrombocytopenic acute leukemic patients with venous thromboembolism at a Comprehensive Cancer Center. Journal of thrombosis and thrombolysis 45(3):377-385, 2018. e-Pub 2018. PMID: 29417408.
      41. Cloyd JM, Nogueras-González GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, Fogelman D, Denbo JW, Garg N, Kim MP, Lee JE, Tzeng CD, Fleming JB, Katz MHG. Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 22(4):1-10, 2018. e-Pub 2018. PMID: 29230694.
      42. Akhtari M, Milgrom SA, Pinnix CC, Reddy JP, Dong W, Smith GL, Mawlawi O, Abou Yehia Z, Gunther J, Osborne EM, Andraos TY, Wogan CF, Rohren E, Garg N, Chuang H, Khoury JD, Oki Y, Fanale M, Dabaja BS. Re-classifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood 131(1):84-94, 2018. e-Pub 2018. PMID: 29038339.
      43. Milgrom SA, Pinnix CC, Chuang H, Oki Y, Akhtari M, Mawlawi O, Garg N, Gunther JR, Reddy JP, Smith GL, Rohren E, Hagemeister FB, Lee HJ, Fayad LE, Dong W, Osborne EM, Abou Yehia Z, Fanale M, Dabaja BS. Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?. Br J Haematol 179(3):488-496, 2017. e-Pub 2017. PMID: 28832956.
      44. Chéry L, Borregales LD, Fellman B, Urbauer DL, Garg N, Parker N, Katz MHG, Wood CG, Karam JA. The effects of neoadjuvant axitinib on anthropometric parameters in patients with locally advanced non-metastatic renal cell carcinoma. Urology 108:114-121, 2017. e-Pub 2017. PMID: 28705573.
      45. Head MD, Working Group NCS. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison. Radiother Oncol 124(2):232-239, 2017. e-Pub 2017. PMID: 28733053.
      46. Wong M, Oo TH, Qiao W, Garg N, Rojas-Hernandez CM. Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer. J Thromb Thrombolysis 44(2):261-266, 2017. e-Pub 2017. PMID: 28677022.
      47. Smith GL, Duvic M, Yehia ZA, Allen P, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Khoury JD, Dabaja BS. Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma. Adv Radiat Oncol 2(3):363-369, 2017. e-Pub 2017. PMID: 29114604.
      48. Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction?. Ann Thorac Surg 103(6):1710-1714, 2017. e-Pub 2017. PMID: 28366460.
      49. Raghavendra A, Sinha AK, Le-Petross HT, Garg N, Hsu L, Patangan M, Bevers TB, Shen Y, Banu A, Tripathy D, Bedrosian I, Barcenas CH. Mammographic breast density is associated with the development of contralateral breast cancer. Cancer 123(11):1935-1940, 2017. e-Pub 2017. PMID: 28135395.
      50. Sridharan R, Engle MP, Garg N, Wei W, Amini B. Focal uptake at the rotator interval or inferior capsule of shoulder on (18)F-FDG PET/CT is associated with adhesive capsulitis. Skeletal Radiol 46(4):533-538, 2017. e-Pub 2017. PMID: 28161721.
      51. Wen G, Rodriguez-Niño B, Pecen FY, Vining DJ, Garg N, Markey MK. Comparative study of computational visual attention models on two-dimensional medical images. J Med Imaging (Bellingham) 4(2):025503, 2017. e-Pub 2017. PMID: 28523282.
      52. Raj SD, Amer AM, Garg N, Krishnamurthy S, Hess KR, Park YM, Moseley T, Whitman GJ. Incidental suspicious regional lymph nodes on breast sonography: is sampling necessary?. Curr Probl Diagn Radiol 46(2):100-104, 2017. e-Pub 2017. PMID: 27338308.
      53. Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, Rohren E, Garg N, Chuang H, Yehia ZA, Reddy JP, Gunther JR, Khoury JD, Suki T, Osborne EM, Oki Y, Fanale M, Dabaja BS. Chemotherapy response assessment by FDG-PET-CT in early-stage classical Hodgkin lymphoma: moving beyond the five-point Deauville score. Int J Radiat Oncol Biol Phys 97(2):333-338, 2017. e-Pub 2017. PMID: 28068241.
      54. Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. Am J Hematol 92(2):155-160, 2017. e-Pub 2017. PMID: 27874212.
      55. Garg N, Elshikh M, Rayan J, Wei P, Rajaram V, Bhosale P. Differentiating Pancreatic Cystic Lesion. Clin Oncol 1(1088), 2016. e-Pub 2016.
      56. Chauhan A, Faizi NA, Chen YJ, Jones LP, Garg N, Bhosale PR. Role of ultrasound in complications of hematopoetic stem cell transplantation. Ultrasound Q 32(3):212-23, 2016. e-Pub 2016. PMID: 27556191.
      57. Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH. Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer. Ann Surg Oncol 22(7):2416-23, 2015. e-Pub 2015. PMID: 25519927.
      58. Chauhan A, Garg N, Menias CO, Devine CE, Bhosale PR, Balachandran A. Tumor thrombus as a rare presentation of lymphoma: a case series of 14 patients. AJR Am J Roentgenol 204(4):W398-404, 2015. e-Pub 2015. PMID: 25794089.
      59. Fogelman DR, Holmes H, Mohammed K, Katz MH, Prado CM, Lieffers J, Garg N, Varadhachary GR, Shroff R, Overman MJ, Garrett C, Wolff RA, Javle M. Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?. J Cachexia Sarcopenia Muscle 5(4):307-13, 2014. e-Pub 2014. PMID: 24740741.
      60. Burger JA, Keating MJ, Wierda WG, Hartmann E, Hoellenriegel J, Rosin NY, de Weerdt I, Jeyakumar G, Ferrajoli A, Cardenas-Turanzas M, Lerner S, Jorgensen JL, Nogueras-González GM, Zacharian G, Huang X, Kantarjian H, Garg N, Rosenwald A, O'Brien S. Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study. Lancet Oncol 15(10):1090-9, 2014. e-Pub 2014. PMID: 25150798.
      61. Wodarz D, Garg N, Komarova NL, Benjamini O, Keating MJ, Wierda WG, Kantarjian H, James D, O'Brien S, Burger JA. Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib. Blood 123(26):4132-5, 2014. e-Pub 2014. PMID: 24829205.
      62. Surabhi VR, Garg N, Frumovitz M, Bhosale P, Prasad SR, Meis JM. Aggressive angiomyxomas: a comprehensive imaging review with clinical and histopathologic correlation. AJR Am J Roentgenol 202(6):1171-8, 2014. e-Pub 2014. PMID: 24848813.
      63. Muralidhar GS, Markey MK, Bovik AC, Haygood TM, Stephens TW, Geiser WR, Garg N, Adrada BE, Dogan BE, Carkaci S, Khisty R, Whitman GJ. Stereoscopic interpretation of low -dose breast tomosynthesis projection images. J Digit Imaging 27(2):248-54, 2014. e-Pub 2014. PMID: 24190140.
      64. Tanasanvimon S, Garg N, Viswanathan C, Truong M, Kaur H, Kee BK, Sahin IH, Javle MM, Garrett CR. High prevalence of recurrent thrombosis in subsets of cancer patients with isolated gonadal vein thrombosis: A single center retrospective study. Thromb Res 133(2):154-7, 2014. e-Pub 2014. PMID: 24331209.
      65. Kang HC, Menias CO, Gaballah AH, Shroff S, Taggart MW, Garg N, Elsayes KM. Beyond the GIST: mesenchymal tumors of the stomach. Radiographics 33(6):1673-1690, 2013. e-Pub 2013. PMID: 24108557.
      66. Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?. World J Radiol 5(6):241-7, 2013. e-Pub 2013. PMID: 23807902.
      67. Ganeshan DM, Salem U, Viswanathan C, Balachandran A, Garg N, Silverman P, Bhosale P. Complications of oncologic therapy in the abdomen and pelvis: a review. Abdom Imaging 38(1):1-21, 2013. e-Pub 2013. PMID: 22644726.
      68. Smith GL, Duvic M, Yehia ZA, Allen P, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Khoury JD, Dabaja BS. Low-dose radiation for primary cutaneous anaplastic large cell lymphoma: a retrospective patient series. Advances in Radiation Oncology.

      Review Articles

      1. Mujtaba B, Nassar SM, Aslam R, Garg N, Madewell JE, Taher A, Hanafy AK, Whitman G. Primary Osteosarcoma of the Breast: Pathophysiology and Imaging Review. Curr Probl Diagn Radiol. e-Pub 2019. PMID: 30655112.
      2. Korivi BR, Javadi S, Faria S, Sagebiel T, Garg N, Patnana M, Prasad SR. Small cell carcinoma of the ovary, hypercalcemic type: Clinical and imaging review. Current problems in diagnostic radiology 47(5):333-339, 2018. e-Pub 2018. PMID: 28943050.
      3. Cox VL, Saeed Bamashmos AA, Foo WC, Gupta S, Yedururi S, Garg N, Kang HC. Lynch Syndrome: Genomics update and imaging review. Radiographics: a review publication of the Radiological Society of North America, Inc 38(2):488-489, 2018. e-Pub 2018. PMID: 29528821.
      4. Viswanathan C, Truong M, Sagebiel T, Garg N, Bhosale P. Imaging of chemotherapy-related iatrogenic abdominal and pelvic conditions. Radiol Clin North Am 52(5):1029-40, 2014. e-Pub 2014. PMID: 25173656.

      Professional Educational Materials

      1. Garg N. Garglets: various software plugins for PACS in use by over 50 radiologists and trainees at UT MDACC.

      Other Articles

      1. Abelhad, NI, Qiao, W, Garg, N, Rojas Hernandez, CM Correction to. Thrombosis Journal 19(1), 2021. PMID: 34261491.

      Abstracts

      1. Ganapathi T, Bassett RL, Garg N, Vining DJ, Markey MK. Man-machine interface for radiology reporting: identification of key sources of variability. Biomedical Engineering Society Annual Meeting 2012, 2012. e-Pub 2012.
      2. Garg N, Bandari M, Wagner-Bartak N, Neperdu J, Mukai J, Kundra V, Vining D. Semiautomated measurements of renal cysts. American Journal of Roentgenology 196(5_Supplement):A7 - A10, 2011. e-Pub 2011.
      3. Vining DJ, Garg N, Markey MK, Ganapathi T, Komogortsev O. Principles and radiologic applications of eye-tracking technology. American Journal of Roentgenology 196(5_Supplement):A120 - A134, 2011. e-Pub 2011.
      4. Wagner-Bartak N, Marcal L, Garg N, Szklaruk J. Imaging of extrahepatic bile duct cancer: implications of the revised AJCC staging classification. American Journal of Roentgenology 196(5_Supplement):A149 - A176, 2011. e-Pub 2011.
      5. Vining D, Tsimberidou A, Wang J, Garg N. Multimedia structured reporting: a picture is worth a thousand words. American Journal of Roentgenology 196(5_Supplement):A10 - A13, 2011. e-Pub 2011.
      6. Garg N, Wagner-Bartak N, Mukai J, Elsayes K, Ernst R, Neperdu J, Kundra V, Vining D. Automated midline shift detection on head computer tomography. American Journal of Roentgenology 196(5_Supplement):A10 - A13, 2011. e-Pub 2011.
      7. Elsayes K, Menias C, Vikram V, Garg N, Patnana M, Devine C, Platt J. Imaging of the gallbladder wall; a pattern recognition approach on CTR and magnetic resonance imaging pathological correlation. The Society of Gastrointestinal Radiologists/Abdominal Radiology Course, 2011. e-Pub 2011.
      8. Ganapathi T, Markey M, Vining D, Garg N. Towards automatic structured reporting in radiology: paired gaze and speech analysis. XIV Medical Image Perception Society Conference 2011, 2011. e-Pub 2011.
      9. Markey M, Bovik A, Stephens T, Haygood T, Geiser W, Garg N, Whitman G. Stereoscopic viewing of tomosynthesis projection images. XIV Medical Image Perception Society Conference 2011, 2011. e-Pub 2011.
      10. Kramer L, Garg N. Triple inversion recovery imaging of myocardial infarction. Proceedings of Joint Meeting of the International Society of Magnetic Resonance in Medicine and the European Society of Magnetic Resonance in Medicine and Biology, 2010. e-Pub 2010.
      11. Garg N, Cheung A, Kowal D, Mukai J. Summary impressions: selecting how many and which prior radiology examinations to review. Proceedings of 57th Annual Meeting of the Association of University Radiologists, 2009. e-Pub 2009.
      12. Green A, Garg N. A radiology information system (RIS) search-based approach to rare case interpretation. Proceedings of Annual Meeting of the American Roentgen Ray Society, 2009. e-Pub 2009.
      13. Garg N. Computer-assisted automatic report generation of DEXA scans. Proceedings of Indian Radiology and Imaging Association Annual Meeting, 2008. e-Pub 2008.
      14. Pyrros A, Garg N. Faster radiology reporting through the utilization of standardized macros. Proceedings of 56th Annual Meeting of the Association of University Radiologists, 2008. e-Pub 2008.
      15. Garg N, Akkanti B, Narvy S, Sekra A, Bader D. Mashdot: a web-based medical journal club. American Journal of Roentgenology 188(5_Supplement):A10, 2007. e-Pub 2007.
      16. Garg N, Chang A. Wiki-based collaborative web page for residents. American Journal of Roentgenology 186(4_Supplement):A30, 2006. e-Pub 2006.

      Book Chapters

      1. Vinnicombe SJ, Garg N. Hematologic Malignancy: The Lymphomas. In: Oncologic Imaging: A Multidisciplinary Approach. 2nd. Saunders, 529-554, 2022.

      Books (edited and written)

      1. Vinnicombe, S, Garg, N. Hematologic Malignancy, 2022.

      Patents

      1. Method and Apparatus for Providing Measurement Data of an Anomaly in a Medical Image. Patent Number: 8,290,231.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top